Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Share this content:
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Sponsors and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
NCIC Clinical Trials Group

Principal Investigators
James A. Eastham, MD, Memorial Sloan-Kettering Cancer Center
Martin G. Sanda, MD, Beth Israel Deaconess Medical Center
Martin E. Gleave, MD, Vancouver General Hospital

ClinicalTrials.gov Identifier
NCT00430183

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters